The efficacy and safety of probiotics in peopl... - CLL Support
The efficacy and safety of probiotics in people with cancer: a systematic review
You need to be a member of this community to see this post.
Read more about...
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Efficacy and safety of new‑generation BTKis (primarily acalabrutinib and zanubrutinib) in CLL/SLL: a systematic review and meta‑analysis
The meta-analysis of 20 studies on CLL/SLL patients treated with new-generation BTKis was based on...
Efficacy of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a systematic review and meta-analysis
Given the interest in my recent response to @[571533] about whether our immune system will get...
RICHTER'S TRANSFORMATION IN PATIENTS WITH CLL: ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES
A number of abstracts are now available from the EHA meeting last week. One of the papers that...
Factors Identified for Risk of Second Cancer in CLL Following BTK Inhibition
There was hope that non-chemo CLL treatments would avoid the increased risk of subsequent secondary...
FDA Frontline Approval of Venetoclax and Obinituzumab in the USA
Hi,
Venetoclax in combination with obinutuzumab has been approved frontline for CLL. This is the...
Related Posts
Role of RITUXIMAB in CLL treatment in combination with Venetoclax- Is there anyone with experience in bladder cancer treatment?
- CLL - a Cancer of the Immune System
- IgG Testing, Immunoglobulin Replacement Therapy, and Infection Outcomes in Patients with CLL or NHL: Real-World Evidence
Skin Cancer and CLL a Mayo community study...
